Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trialLetter Published on 2020-06-032022-10-29 Journal: Trials [Category] [DOI] 10.1186/s13063-020-04400-4 PMC 바로가기 [Article Type] Letter
Products in a Pandemic: Liability for Medical Products and the Fight against COVID-19Articles Published on 2020-05-202022-10-31 Journal: European Journal of Risk Regulation [Category] [DOI] 10.1017/err.2020.54 PMC 바로가기 [Article Type] Articles
MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and EfficacyImmunology Published on 2020-05-192022-11-01 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2020.01091 PMC 바로가기 [Article Type] Immunology
Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2)Article Published on 2020-05-122022-10-30 Journal: Molecules [Category] [DOI] 10.3390/molecules25102271 PMC 바로가기 [Article Type] Article
Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling StudyArticle Published on 2020-04-232022-10-30 Journal: Marine Drugs [Category] [DOI] 10.3390/md18040225 PMC 바로가기 [Article Type] Article
Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trialDNA 또는 NYVAC 벡터(HVTN 096)가 있는 외피 단백질을 포함하는 다가 HIV 백신의 안전성 및 면역원성: 1b상, 이중 맹검, 위약 대조 시험Article Published on 2019-10-072022-09-06 Journal: The Lancet. HIV [Category] [DOI] 10.1016/S2352-3018(19)30262-0 PMC 바로가기 [Article Type] Article